Compare HYPR & ATRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | HYPR | ATRA |
|---|---|---|
| Founded | 2014 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 101.3M | 81.2M |
| IPO Year | 2021 | 2014 |
| Metric | HYPR | ATRA |
|---|---|---|
| Price | $0.79 | $9.57 |
| Analyst Decision | Strong Buy | Sell |
| Analyst Count | 4 | 2 |
| Target Price | $1.59 | ★ $5.00 |
| AVG Volume (30 Days) | ★ 489.6K | 50.8K |
| Earning Date | 05-12-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 23.21 | ★ 122.52 |
| EPS | ★ N/A | N/A |
| Revenue | $13,563,000.00 | ★ $120,772,000.00 |
| Revenue This Year | $50.75 | N/A |
| Revenue Next Year | $29.71 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 5.22 | N/A |
| 52 Week Low | $0.79 | $3.92 |
| 52 Week High | $2.22 | $19.15 |
| Indicator | HYPR | ATRA |
|---|---|---|
| Relative Strength Index (RSI) | 29.06 | 54.82 |
| Support Level | N/A | $8.98 |
| Resistance Level | $1.39 | $10.02 |
| Average True Range (ATR) | 0.04 | 0.53 |
| MACD | 0.00 | 0.06 |
| Stochastic Oscillator | 5.22 | 34.39 |
Hyperfine Inc is a medical device company that created Swoop. The Swoop Portable MR Imaging System produces high-quality images at a lower magnetic field strength than conventional MRI scanners. The company derives its revenue from sale of sales of MRI devices and service sales, which consist of sales from subscriptions of bundled devices, maintenance, and software. The company is in the health technology business with a mission to revolutionize patient care globally through accessible, affordable, clinically relevant artificial intelligence (AI)-powered portable ultra-low-field (ULF) magnetic resonance (MR) brain imaging. The Company operates in one business segment, which includes all activities related to production, supply, service, and commercialization of the Swoop system.
Atara Biotherapeutics Inc operates in the United States healthcare sector. It focuses on developing transformative therapies for patients with serious diseases, including solid tumors, hematologic cancers, and autoimmune diseases. It operates and manages business as one operating and reportable segment which is the business of developing therapeutics. The company's product candidates comprise Tab-cel, ATA3431, and ATA3219.